Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
M.E. De Tomás, S. Beltrán, S. Molina.
Artralgias invalidantes secundarias al tratamiento con pioglitazona.
Endocrinol Nutr, 51 (2004), pp. 446
[2.]
C.A. Naranjo, U. Busto, E.M. Sellers, P. Sandor, I. Ruiz, E.A. Roberts, et al.
A method for estimating the probability of adverse drug reactions.
Clin Pharmacol Ther, 30 (1981), pp. 239-245
[3.]
Ficha técnica Actos™.
[4.]
Data on file, Lilly-Takeda laboratories.
[5.]
L. Jovanovic, D.R. Hassman, B. Gooch, R. Jain, S. Greco, N. Khutoryansky, et al.
Treatment of type 2 diabetes with a combination regimen of repaglinide plus pioglitazone.
Diabet Res Clin Pract, 63 (2004), pp. 127-134
[6.]
Z. Yuan, Y. Liu, Y. Liu, J. Zhang, C. Kishimoto, Y. Wang, et al.
Peroxisome proliferation-activated receptor-gamma ligands ameliorate experimental autoimmune myocarditis.
Cardiovasc Res, 59 (2003), pp. 685-694
[7.]
M. Ishibashi, K. Egashira, K. Hiasa, S. Inoue, W. Ni, Q. Zhao, et al.
Antiinflammatory and antiarterioesclerotic effects of pioglitazone.
Hypertension, 40 (2002), pp. 687-693
[8.]
Pillarisetti S, et al. Vascular anti-inflammatory effects of TZD's may not require PPAR-gamma activation. Second International Symposium on PPARs: from basic science to applications. Florence; 2003, marzo; p. 19-22.
[9.]
A. Pérez, T. Johnson, M. Karunaratne.
Pioglitazone in combination with insulin reduces highly sensitive c-reactive protein blood levels in subjects with type 2 diabetes.
Diabetes Metab, 29 (2003), pp. 4-253
[10.]
S. Sundararajan, G.E. Landreth.
Antiinflammatory properties of PPARgamma agonists following ischemia.
Drug News Perspectives, 17 (2004), pp. 229-236
[11.]
Y. Miyazaki, A. Mahankali, E. Wajcberg, M. Bajaj, L.J. Mandarino, R.A. DeFronzo, et al.
Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients.
J Clin Endocrinol Metabol, 89 (2004), pp. 4312-4319
[12.]
J.M. Fernández-Real, W. Ricart.
Insulin resistance and chronic cardiovascular inflammatory syndrome.
Endocr Rev, 24 (2003), pp. 278-330
Copyright © 2005. Sociedad Española de Endocrinología y Nutrición